Fig 1: Cluster identity reveals heterogenous microglial population.(a) Heatmap showing top-5 marker genes identified from each cluster. Complete list of marker genes can be found in Figure 2—source data 1. Annotation for each cluster is shown on the right. (b–e) Violin plot showing expression of selected marker genes in Cluster-1 (b), Cluster-3 (c), Cluster-4 (d) and Cluster-5 (e) in naïve C57BL/6J mice (Ctrl), PLX-treated mice (D0, 2 weeks of PLX diet) and repopulating (D2, 2 days after the end of treatment) brains. (f) Ridge plot showing expression of Cd74 in clusters 1–5. (g) Representative confocal images showing immunofluorescence staining of CD74 (green) and IBA1(red) in Ctrl and D0 brains. Images were taken from the fimbria (FI). Figure 2—source data 1.DEGs for each cluster vs all other clusters.
Fig 2: Ridge plot shows Comparison of expression levels of CD74 and MHCs in clusters1–5.Cells in cluster 5 have the highest levels of CD74, H2-Eb1, H2-Aa and H2-Ab1. Among them, CD74 exhibit the highest level.
Fig 3: ATV:4D9 induces temporally dynamic microglial morphology and marker expression.(a) Representative morphometric images of microglia in the cortex 1 day post dose with ATV:ISO or ATV:4D9 (10 mg kg-1) at day 1-, 7-, 14-, and 28-days post dose. (b) UMAP plot of all microglia over time. (c) Percentage of microglia in the responsive cluster as a proportion of all segmented microglia over time (n = 3 male mice per group, two-tailed unpaired t-test between ATV:ISO and ATV:4D9 at day 1, mean ± SEM). (d) Volcano plot showing the top 6 differentially high and low normalized features comparing the responsive cluster to the homeostatic cluster. (e) Heatmap of normalized features for all segmented microglia (1,143 total cells) over time, measured across 65 morphometric and immunohistochemical features, grouped by treatment (rows) with features hierarchically clustered (columns). (f) Representative images of cortical brain sections co-stained with Iba1 and CD74 at 1-, 7-, 14-, 28-days days post 10 mg kg-1 dose of ATV:ISO or ATV:4D9. CD74+ microglia are noted with white arrows. (g) Mean intensity of CD74 staining within segmented IBA1+ microglia normalized to background CD74 intensity at each timepoint (n = 5 mice/group, two-tailed unpaired t-test between ATV:ISO and ATV:4D9 at day 1, mean ± SEM). (h) Representative images of cortical brain sections stained for IBA1 and AXL 1 day post dose of ATV:ISO or ATV:4D9. Double positive microglia are noted with white arrows. (i) Quantification of mean intensity of AXL staining within segmented IBA1+ microglia normalized to background (n = 5 mice/group, two-tailed unpaired t-test, mean ± SEM).
Fig 4: Inhibiting Cd74 ameliorated experimental autoimmune uveitis (EAU) disease phenotype. (A) Schematic diagram of subretinal injection of the polyclonal anti‐Cd74 antibody or neutralizing Ccl5 (neuCcl5) antibody. (B, C) The clinical symptoms and scores in the EAU + immunoglobulin G (IgG) and EAU + anti‐Cd74 groups on D14. n = 5 mice per group. (white arrows, conjunctival and/or ciliary congestion; yellow arrows, synechiae). (D, E) Retinal histopathological staining and scores in the EAU + IgG and EAU + anti‐Cd74 groups on D14. n = 5 mice per group. (scale bar, 200 µm; yellow arrows, infiltration of inflammatory cells; white arrows, retinal folds). (F) Retinal microglia (Tmem119+) staining in the EAU + IgG and EAU + anti‐Cd74 groups on D14. (scale bar, 20 µm; yellow arrows, amoeboid microglia; white arrows, ramified microglia). (G, H) The retinal protein expression of interleukin 6 (IL‐6) in the EAU + IgG and EAU + anti‐Cd74 groups. (I, J) The retinal protein expression of nuclear factor‐kappa B (NF‐κB) factors in the EAU + IgG and EAU + anti‐Cd74 groups. * p < 0.05, ** p < 0.01, NS: no significance.
Fig 5: Identification of disease‐associated retinal microglia at the experimental autoimmune uveitis (EAU) peak. (A) t‐distributed stochastic neighbor embedding (t‐SNE) plots of microglial cells on D0 and D14 split by subpopulations and time points. (B) Heatmap of the top 10 differentially expressed genes (DEGs) expressed in each microglial subpopulation on D0 and D14. (C) Volcano plot of the DEGs between non‐inflammatory microglia (NIM) and inflammation‐associated microglia (IAM). (D) t‐SNE plots of Cd74 and Ccl5 expressed in microglial subpopulations on D0 and D14. (E) Retinal mRNA expression of Cd74 and Ccl5 in the D0 group and D14 EAU group. (F) Representative images of retinal microglia (Tmem119+) co‐stained with Cd74 and Ccl5 in the D0 group and D14 EAU group. (scale bar, 20 µm; white arrows, Cd74− Ccl5− microglia; yellow arrows, Cd74+ Ccl5+ microglia). * p < 0.05, ** p < 0.01.
Supplier Page from Abcam for Anti-CD74 antibody [In-1]